Pasadena, CA, United States of America

Lee Joon Kim

This inventor holds 1 USPTO granted patent. Top assignees: California Institute of Technology, University of California. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lee Joon Kim: Innovator in Drug Discovery Technology

Introduction

Lee Joon Kim is an accomplished inventor based in Pasadena, CA. He has made significant contributions to the field of drug discovery, particularly through his innovative patent. His work focuses on enhancing the efficiency of drug discovery processes, which is crucial in the pharmaceutical industry.

Latest Patents

Lee Joon Kim holds a patent for a high throughput drug discovery platform utilizing transmission electron microscopy (TEM). This patent, which is pivotal in the realm of drug development, relates to methods of obtaining electron diffraction data from microcrystalline samples. His innovative approach aims to streamline the drug discovery process, making it faster and more effective.

Career Highlights

Throughout his career, Lee has worked with prestigious institutions such as the California Institute of Technology and the University of California. His experience in these renowned organizations has allowed him to develop and refine his expertise in drug discovery technologies.

Collaborations

Lee has collaborated with notable colleagues, including Jessica Burch and Hosea Nelson. These partnerships have contributed to his research and the advancement of his innovative ideas in the field.

Conclusion

Lee Joon Kim is a prominent figure in the field of drug discovery, with a focus on innovative technologies that enhance the efficiency of the process. His contributions, including his patent and collaborations, reflect his commitment to advancing pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…